Improving the refolding yield of interleukin-4 through the optimization of local interactions.

Interleukin-4 (IL-4) is a multifunctional cytokine that plays an important role in the regulation of various immune responses. However, the development of IL-4 or IL-4 variants into potential therapeutic drugs is hindered by the low efficiency of the in vitro refolding process of this protein. In this work, we have investigated the improvement of the refolding yield of IL-4 using two different rational design approaches. The first one is based on the so-called inverse hydrophobic effect and involved the replacement of a solvent exposed, non-conserved, hydrophobic residue (W91) by serine. This led to an increase in stability of 1.4 kcal mol(-1) and shifted the midpoint transition temperature (Tm) from 62 to 70 degrees C. The second approach is based on the stabilization of alpha-helices through the introduction of favorable local interactions. This strategy resulted in the following helix sequence for helix C of IL-4, 68ASAAEANRHKQLIRFLKRLDRNLWGLAG95. The mutant protein was stabilized by 0.5 kcal mol(-1), the Tm shifted to 68 degrees C, and a two-fold increase in the refolding yield was consistently observed. Our results make the large-scale production of IL-4 derivatives economically more viable, suggest that a similar approach can be applied to other related proteins, and may represent a general strategy to improve in vitro refolding yields through the selective optimization of the stability of alpha-helices.

[1]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[2]  D. Le-Nguyen,et al.  PyBOP®: A new peptide coupling reagent devoid of toxic by-product , 1990 .

[3]  G. Han,et al.  9-Fluorenylmethoxycarbonyl amino-protecting group , 1972 .

[4]  D. W. Bolen,et al.  Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. , 1988, Biochemistry.

[5]  G. Roberts,et al.  NMR of macromolecules : a practical approach , 1993 .

[6]  V. Muñoz,et al.  Kinetic characterization of the chemotactic protein from Escherichia coli, CheY. Kinetic analysis of the inverse hydrophobic effect. , 1994, Biochemistry.

[7]  P. S. Kim,et al.  Intermediates in the folding reactions of small proteins. , 1990, Annual review of biochemistry.

[8]  P. Reinemer,et al.  Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface , 1999, Cell.

[9]  M. Hyvönen,et al.  T7 vectors with modified T7lac promoter for expression of proteins in Escherichia coli. , 1996, Analytical biochemistry.

[10]  L Serrano,et al.  Analysis of the effect of local interactions on protein stability. , 1996, Folding & design.

[11]  H. Renz,et al.  Role and modulation of T-cell cytokines in allergy. , 1995, Current opinion in immunology.

[12]  K. Wüthrich.  NMR of proteins and nucleic acids , 1988 .

[13]  R A Smith,et al.  Human interleukin 4. The solution structure of a four-helix bundle protein. , 1992, Journal of molecular biology.

[14]  R. Kastelein,et al.  Expression, renaturation and purification of recombinant human interleukin 4 from Escherichia coli. , 1988, European journal of biochemistry.

[15]  Y H Chen,et al.  Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. , 1974, Biochemistry.

[16]  P. Heinrich,et al.  Development of a human interleukin-6 receptor antagonist. , 1994, The Journal of biological chemistry.

[17]  A. Gustchina,et al.  Crystal structure of human recombinant interleukin‐4 at 2.25 Å resolution , 1992, FEBS letters.

[18]  W. Paul,et al.  Lymphocyte responses and cytokines , 1994, Cell.

[19]  D. Brems.  Solubility of different folding conformers of bovine growth hormone , 1988 .

[20]  L. J. Perry,et al.  Mutations in Human Interferon Gamma Affecting Inclusion Body Formation Identified by a General Immunochemical Screen , 1991, Bio/Technology.

[21]  A. Fink.  Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.

[22]  G. Wider,et al.  NMR determination of residual structure in a urea-denatured protein, the 434-repressor. , 1992, Science.

[23]  W. Sebald,et al.  Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. , 1993, The EMBO journal.

[24]  J. Tavernier,et al.  Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Sebald,et al.  IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. , 1997, International immunology.

[26]  V. Muñoz,et al.  Intrinsic secondary structure propensities of the amino acids, using statistical ϕ–ψ matrices: Comparison with experimental scales , 1994 .

[27]  H. Tschesche.  Modern methods in protein chemistry , 1983 .

[28]  H. Lowman,et al.  Affinity maturation of human growth hormone by monovalent phage display. , 1993, Journal of molecular biology.

[29]  D. Goeddel,et al.  Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.

[30]  W. Wood,et al.  Mechanism-based design of prolactin receptor antagonists. , 1993, The Journal of biological chemistry.

[31]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[32]  J. Pieters.  Protein folding coupled to disulphide bond formation. , 1997 .

[33]  Robert T. Sauer,et al.  Reverse hydrophobic effects relieved by amino-acid substitutions at a protein surface , 1990, Nature.

[34]  C. Pace,et al.  How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.

[35]  J. Kinsella,et al.  A method for the controlled cleavage of disulfide bonds in proteins in the absence of denaturants. , 1985, Journal of biochemical and biophysical methods.

[36]  L. Aarden,et al.  Development of Human IL‐6 Receptor Antagonists , 1995, Annals of the New York Academy of Sciences.

[37]  L Serrano,et al.  Favourable native-like helical local interactions can accelerate protein folding. , 1997, Folding & design.

[38]  Villegas,et al.  Stabilization of proteins by rational design of alpha-helix stability using helix/coil transition theory. , 1995, Folding & design.

[39]  L Serrano,et al.  Elucidating the folding problem of alpha-helices: local motifs, long-range electrostatics, ionic-strength dependence and prediction of NMR parameters. , 1998, Journal of molecular biology.

[40]  W. Paul,et al.  The IL-4 receptor: signaling mechanisms and biologic functions. , 1999, Annual review of immunology.

[41]  T. Hage,et al.  Global and Local Determinants for the Kinetics of Interleukin‐4/Interleukin‐4 Receptor α Chain Interaction , 1996 .

[42]  W. Windsor,et al.  Analysis of the conformation and stability of Escherichia coli derived recombinant human interleukin 4 by circular dichroism. , 1991, Biochemistry.

[43]  R. L. Baldwin,et al.  Stability of alpha-helices. , 1995, Advances in protein chemistry.

[44]  W. Sebald,et al.  Site‐directed mutagenesis reveals the importance of disulfide bridges and aromatic residues for structure and proliferative activity of human Interleukin‐4 , 1991, FEBS letters.

[45]  C. Pace.  Determination and analysis of urea and guanidine hydrochloride denaturation curves. , 1986, Methods in enzymology.

[46]  Christopher M. Dobson,et al.  Structural characterization of a highly–ordered ‘molten globule’ at low pH , 1994, Nature Structural Biology.

[47]  J. Kinsella,et al.  Effect of oxidative sulfitolysis of disulfide bonds of bovine serum albumin on its structural properties: A physicochemical study , 1988, Journal of protein chemistry.

[48]  D. Shortle.  The denatured state (the other half of the folding equation) and its role in protein stability , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  Seiki Kuramitsu,et al.  Insights into thermal resistance of proteins from the intrinsic stability of their α‐helices , 1997 .

[50]  K. Smith,et al.  Mutagenic analysis of a receptor contact site on interleukin-2: preparation of an IL-2 analog with increased potency. , 1994, Biochemistry.

[51]  D. Brems,et al.  Evidence for a self-associating equilibrium intermediate during folding of human growth hormone. , 1993, Biochemistry.

[52]  W. Sebald,et al.  Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. , 1994, European journal of biochemistry.

[53]  L Serrano,et al.  Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. , 1997, Biopolymers.

[54]  D. Belin,et al.  Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. , 1993, Science.

[55]  S E Ealick,et al.  Crystal structure of recombinant human interleukin-4. , 1994, The Journal of biological chemistry.

[56]  Y. Wang,et al.  A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor α chain , 1997 .

[57]  P. Wright,et al.  ‘Random coil’ 1H chemical shifts obtained as a function of temperature and trifluoroethanol concentration for the peptide series GGXGG , 1995, Journal of biomolecular NMR.

[58]  D. S. Garrett,et al.  The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy. , 1993, Biochemistry.